Related Experiment Video
Updated: Sep 2, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
1Dermatology, Basildon University Hospital, Basildon, GBR.
Abstract:
Vaccination has made a substantial contribution to global health improvement throughout history. The coronavirus disease 2019 (COVID-19) vaccinations have provided us with a ray of hope for combatting the ongoing pandemic and saving lives. However, following COVID-19 vaccination, a wide spectrum of cutaneous adverse effects have been observed. We report a case of dyshidrosiform bullous pemphigoid, a rare clinical variant of bullous pemphigoid, following COVID-19 vaccination in an elderly female patient. The biopsy revealed subepidermal splitting with positive direct and indirect immunofluorescence studies.
Related Concept Videos
Cross-reactivity
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Allergic Drug Reactions

